Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H11NO2 |
| Molecular Weight | 165.1891 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(O)C=C2CNCCC2=C1
InChI
InChIKey=MBFUSGLXKQWVDW-UHFFFAOYSA-N
InChI=1S/C9H11NO2/c11-8-3-6-1-2-10-5-7(6)4-9(8)12/h3-4,10-12H,1-2,5H2
| Molecular Formula | C9H11NO2 |
| Molecular Weight | 165.1891 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of salsolinol, norsalsolinol, and twenty-one biogenic amines using micellar electrokinetic capillary chromatography-electrochemical detection. | 2010-06 |
|
| The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease. | 2009-01 |
|
| Localization of N-methyl-norsalsolinol within rodent and human brain. | 2008-08-15 |
|
| Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines. | 2008-05 |
|
| SAR studies of capsazepinoid bronchodilators. Part 2: Chlorination and catechol replacement in the A-ring. | 2008-03-01 |
|
| Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? | 2007-12-10 |
|
| Reactions of D-glucose with phenolic amino acids: further insights into the competition between Maillard and Pictet-Spengler condensation pathways. | 2005-12-30 |
|
| Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. | 2005-01 |
|
| Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease. | 2004-04 |
|
| Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective. | 2003-07 |
|
| N-methyl-norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioural changes. | 2003-03 |
|
| Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter. | 2001-06 |
|
| Inhibitory effects of endogenous dopaminergic neurotoxin, norsalsolinol on dopamine secretion in PC12 rat pheochromocytoma cells. | 2001-06 |
|
| Norsalsolinol uptake into secretory vesicles via vesicular monoamine transporter and its secretion by membrane depolarization or purinoceptor stimulation in PC12 cells. | 2001-05 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:51:56 GMT 2025
by
admin
on
Mon Mar 31 19:51:56 GMT 2025
|
| Record UNII |
9SPO03ZH41
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID90188366
Created by
admin on Mon Mar 31 19:51:56 GMT 2025 , Edited by admin on Mon Mar 31 19:51:56 GMT 2025
|
PRIMARY | |||
|
NORSALSOLINOL
Created by
admin on Mon Mar 31 19:51:56 GMT 2025 , Edited by admin on Mon Mar 31 19:51:56 GMT 2025
|
PRIMARY | |||
|
34827-33-3
Created by
admin on Mon Mar 31 19:51:56 GMT 2025 , Edited by admin on Mon Mar 31 19:51:56 GMT 2025
|
PRIMARY | |||
|
9SPO03ZH41
Created by
admin on Mon Mar 31 19:51:56 GMT 2025 , Edited by admin on Mon Mar 31 19:51:56 GMT 2025
|
PRIMARY | |||
|
36937
Created by
admin on Mon Mar 31 19:51:56 GMT 2025 , Edited by admin on Mon Mar 31 19:51:56 GMT 2025
|
PRIMARY |